Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith D Lindor

Showing results (111-120 of 261) with videos related to

Pageof 27
Sort By:
Intractable & Rare Diseases Research|February 13, 2015
Current research on the treatment of primary sclerosing cholangitisAhmad H Ali, Elizabeth J Carey, Keith D Lindor
World Journal of Gastroenterology|February 21, 2019
Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategiesBrian M Fung, Keith D Lindor, James H Tabibian
Gastroenterology & Hepatology|July 12, 2018
Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and TreatmentJames H Tabibian, Ahmad H Ali, Keith D Lindor
Biomed Research International|November 16, 2013
Role of the microbiota and antibiotics in primary sclerosing cholangitisJames H Tabibian, Jayant A Talwalkar, Keith D Lindor
Expert Review of Clinical Immunology|November 11, 2014
Diagnosis and management of primary biliary cirrhosisAhmad H Ali, Elizabeth J Carey, Keith D Lindor
Hepatology Communications|February 7, 2018
Update on pharmacotherapies for cholestatic liver diseaseAhmad H Ali, James H Tabibian, Keith D Lindor
Scandinavian Journal of Gastroenterology|July 4, 2014
Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapiesJames H Tabibian, Steven P O'Hara, Keith D Lindor
Journal of Clinical Gastroenterology|July 19, 2003
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosisJoanna L Siegel, Roberta Jorgensen, Paul Angulo, et al.
The American Journal of Gastroenterology|October 19, 2002
Results of long-term ursodiol treatment for patients with primary biliary cirrhosisRoberta Jorgensen, Paul Angulo, E Rolland Dickson, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Advances in primary sclerosing cholangitisJennifer L Horsley-Silva, Elizabeth J Carey, Keith D Lindor
Pageof 27

Showing results (111-120 of 261) with videos related to

Sort By:
Pageof 27
Intractable & Rare Diseases Research|February 13, 2015
Current research on the treatment of primary sclerosing cholangitisAhmad H Ali, Elizabeth J Carey, Keith D Lindor
World Journal of Gastroenterology|February 21, 2019
Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategiesBrian M Fung, Keith D Lindor, James H Tabibian
Gastroenterology & Hepatology|July 12, 2018
Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and TreatmentJames H Tabibian, Ahmad H Ali, Keith D Lindor
Biomed Research International|November 16, 2013
Role of the microbiota and antibiotics in primary sclerosing cholangitisJames H Tabibian, Jayant A Talwalkar, Keith D Lindor
Expert Review of Clinical Immunology|November 11, 2014
Diagnosis and management of primary biliary cirrhosisAhmad H Ali, Elizabeth J Carey, Keith D Lindor
Hepatology Communications|February 7, 2018
Update on pharmacotherapies for cholestatic liver diseaseAhmad H Ali, James H Tabibian, Keith D Lindor
Scandinavian Journal of Gastroenterology|July 4, 2014
Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapiesJames H Tabibian, Steven P O'Hara, Keith D Lindor
Journal of Clinical Gastroenterology|July 19, 2003
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosisJoanna L Siegel, Roberta Jorgensen, Paul Angulo, et al.
The American Journal of Gastroenterology|October 19, 2002
Results of long-term ursodiol treatment for patients with primary biliary cirrhosisRoberta Jorgensen, Paul Angulo, E Rolland Dickson, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Advances in primary sclerosing cholangitisJennifer L Horsley-Silva, Elizabeth J Carey, Keith D Lindor
Pageof 27